Lancet. 1996;348:1055-60. ). In addition, even mild anemia is independently associated with increased comorbid events (cardiac events, pneumonia, urosepsis, venous thromboembolism, postoperative delirium, etc.) at 30 days post-surgery (.
They randomly allocated consecutive patients from the Computerized Registry of Patients with Venous Thromboembolism (RIETE) to a derivation cohort and an internal validation cohort. ... or nonfatal recurrent venous thromboembolism in the same time period.
Which of the following is the most appropriate management of this patient's venous thromboembolism? ... Standard intensity warfarin for at least 3 months is the most appropriate management for patients with risk factors for venous thromboembolism.
65 years of age or older,. history of deep venous thrombosis (DVT) or PE,. ... Symptomatic venous thromboembolism occurred in 7 of 801 patients in the two-point group and in 9 of 763 patients in the whole-leg group.
The study's primary outcome was number of independently adjudicated venous thromboembolism events during three-month follow-up after PE exclusion, while the secondary outcome was the number of required CTPAs ... Eighteen patients in whom PE was excluded
Obtain a detailed history of present illness and medical and family history, with special emphasis on predisposition to, and risk factors for, venous thromboembolism (VTE) as well as a careful physical ... There are no official warnings for other LMWHs.
Pneumonia and venous thromboembolism are common complications post-stroke. In patients with ischemic stroke, rapidly decreasing the blood pressure may be deleterious.
20.9%; P<0.001), and there were no significant differences between groups in myocardial infarction, venous thromboembolism, or death. ... It was also limited by a lower than expected rate of arterial thromboembolism.
Patients with venous thromboembolism (VTE) and significant bleeding risk who got inferior vena cava (IVC) filters had a lower risk of pulmonary embolism (PE)-related death, but a higher risk of
To determine whether autoimmune disorders conferred an excess risk for PE, researchers in Sweden examined data on persons who had not previously been admitted to the hospital for venous thromboembolism and